No interaction between the CCND1 promoter and the IGH enhancers was observed in the absence of chromosomal translocation, as was assessed in the H929 multiple myeloma cells that lack any 11q13 chromosomal rearrangement. The gene discussed is CCND1; the disease is plasma cell myeloma.